Liz Adelanwa
@liz-adel.bsky.social
Health PR flack @ Weber Shandwick. Done time at NICE and Wellcome. Geeks out on sci comms and access stories!
This is such a great piece, thanks for the gift share! Hit a nerve as I've experienced both tracks of this system myself this year. Felt so conflicted when I was lucky enough to get something sorted quickly privately, everyone deserves that!
February 27, 2025 at 5:06 PM
This is such a great piece, thanks for the gift share! Hit a nerve as I've experienced both tracks of this system myself this year. Felt so conflicted when I was lucky enough to get something sorted quickly privately, everyone deserves that!
But if you want a deep dive into EVERY drug approval, there's an article for that too endpts.com/fda-drug-app...
Every FDA drug approval from 2024: Fewer nods, but long-awaited treatments cross the finish line
2024’s novel drug approvals offered a wide array of new cancer drugs, rare disease treatments, a potential Alzheimer’s blockbuster, and about 10 fewer approvals than 2023. While 2022 and 2023 ...
endpts.com
January 6, 2025 at 5:32 PM
But if you want a deep dive into EVERY drug approval, there's an article for that too endpts.com/fda-drug-app...
Healthwatch England or Patients Association might be able to help if you haven't contacted them already!
January 3, 2025 at 1:34 PM
Healthwatch England or Patients Association might be able to help if you haven't contacted them already!